According to Pacific Biosciences 's latest financial reports the company's total assets are $1.74 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $1.74 B | -1.19% |
2022-12-31 | $1.76 B | -11.95% |
2021-12-31 | $2.00 B | 384.8% |
2020-12-31 | $0.41 B | 179.74% |
2019-12-31 | $0.14 B | -13.09% |
2018-12-31 | $0.17 B | 18.18% |
2017-12-31 | $0.14 B | 4.5% |
2016-12-31 | $0.13 B | 5.17% |
2015-12-31 | $0.13 B | 5.4% |
2014-12-31 | $0.12 B | -8.66% |
2013-12-31 | $0.13 B | 5.01% |
2012-12-31 | $0.12 B | -40.6% |
2011-12-31 | $0.21 B | -28.6% |
2010-12-31 | $0.30 B | 202.43% |
2009-12-31 | $0.10 B | -10.62% |
2008-12-31 | $0.11 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $98.72 B | 5,554.38% | ๐บ๐ธ USA |
General Electric GE | $163.04 B | 9,238.15% | ๐บ๐ธ USA |
Illumina ILMN | $10.11 B | 479.09% | ๐บ๐ธ USA |
PerkinElmer
PKI | $14.63 B | 738.38% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
NanoString Technologies NSTG | $0.27 B | -84.27% | ๐บ๐ธ USA |